Article
Federal Court Dismisses Apotex's Application For Judicial Review Regarding Apo-Progesterone ANDS
That the U.S. Food and Drug Administration had previously approved a different drug product with higher levels of SLS did not render the decision unreasonable.
Smart & Biggar